S. Tanaka et al., A novel dominant-negative mutation of the hepatocyte nuclear factor-1 alpha gene in Japanese early-onset type 2 diabetes, HORMONE MET, 32(9), 2000, pp. 373-377
We investigated the presence and the function of hepatocyte nuclear factor-
1 alpha (HNF-1 alpha) mutations in 26 Japanese subjects with type 2 diabete
s. The subjects were between 20 and 39 years of age on diagnosis and had di
abetic first-degree relatives. Two different frameshift mutations were foun
d in 2 subjects (8 %). One novel mutation, T539fsdelC (deletion of C in cod
on 539 for Thr), is predicted to generate a protein of normal 539 residues
at the N-terminus followed by an abnormal 119 amino acid protein. The mutat
ion, P291fsinsC (insertion of C in codon 291 for Pro) should lead to produc
tion of a truncated protein of 315 amino acids. Transfection reporter assay
using MIN6 and HepG2 cells revealed both mutations to have null function i
n the transactivation of reporter gene expression. When transfected with wi
ld-type gene, these mutations behaved as dominant-negative regulators in bo
th cells. An equimolar amount of T539fsdelC reduced wild-type activity by s
imilar to 80% in MIN6 cells, while the same concentration of P291fsinsc red
uced it by 30%. The sequences responsible for the transactivation activity
of HNF-1 alpha are confined largely to amino acids 547-628, so that the T53
9fsdelC mutation,which affects this entire region, replacing amino acids 54
0-631 with an abnormal 119 amino acid protein, may acquire a potent dominan
t-negative function.